Evidence and gaps in the literature on HIV/STI prevention interventions targeting migrants in receiving countries: a scoping review.

Sexually transmitted diseases/STDs behavioural biomedical and/or structural interventions combination prevention population mobility randomised controlled trials/RCT sexual and reproductive health and rights trend statement

Journal

Global health action
ISSN: 1654-9880
Titre abrégé: Glob Health Action
Pays: United States
ID NLM: 101496665

Informations de publication

Date de publication:
01 01 2021
Historique:
entrez: 18 8 2021
pubmed: 19 8 2021
medline: 21 9 2021
Statut: ppublish

Résumé

Evidence suggests that migration increases vulnerability to human immunodeficiency virus (HIV) and other sexually transmitted infections (STI). However, there is limited knowledge about what has been done or needs to be done to address migrants' vulnerability in receiving countries. A scoping review was carried out to map the existing literature in this field, describe its characteristics, identify gaps in knowledge and determine whether a Sexual and Reproductive Health and Rights (SRHR)-perspective was applied. We used the Arksey and O'Malley framework and the Joanna Briggs Institute guidelines for scoping reviews and subsequent enhancements proposed by other authors. We searched three databases and grey literature to identify relevant publications. A total of 1,147 records were found across the three electronic databases and compiled. Of these, only 29 papers that met the inclusion criteria were included. The review shows that research in this field is dominated by studies from the USA that mostly include behavioural interventions for HIV and HBV prevention among migrants from Latin America and Asian countries, respectively. None of the interventions integrated an SRHR perspective. The intervention effects varied across studies and measured outcomes. The observed effects on knowledge, attitudes, perceptions, behavioural intentions and skills were largely positive, but reported effects on testing and sexual risk behaviours were inconsistent. There is a need for good quality research, particularly in parts of the world other than the USA that will address all STIs and specifically target the most vulnerable subgroups of migrants. Further research requires greater scope and depth, including the need to apply an SRHR perspective and incorporate biomedical and structural interventions to address the interacting causes of migrants' vulnerability to HIV/STIs.

Sections du résumé

BACKGROUND
Evidence suggests that migration increases vulnerability to human immunodeficiency virus (HIV) and other sexually transmitted infections (STI). However, there is limited knowledge about what has been done or needs to be done to address migrants' vulnerability in receiving countries.
OBJECTIVES
A scoping review was carried out to map the existing literature in this field, describe its characteristics, identify gaps in knowledge and determine whether a Sexual and Reproductive Health and Rights (SRHR)-perspective was applied.
METHODS
We used the Arksey and O'Malley framework and the Joanna Briggs Institute guidelines for scoping reviews and subsequent enhancements proposed by other authors. We searched three databases and grey literature to identify relevant publications.
RESULTS
A total of 1,147 records were found across the three electronic databases and compiled. Of these, only 29 papers that met the inclusion criteria were included. The review shows that research in this field is dominated by studies from the USA that mostly include behavioural interventions for HIV and HBV prevention among migrants from Latin America and Asian countries, respectively. None of the interventions integrated an SRHR perspective. The intervention effects varied across studies and measured outcomes. The observed effects on knowledge, attitudes, perceptions, behavioural intentions and skills were largely positive, but reported effects on testing and sexual risk behaviours were inconsistent.
CONCLUSIONS
There is a need for good quality research, particularly in parts of the world other than the USA that will address all STIs and specifically target the most vulnerable subgroups of migrants. Further research requires greater scope and depth, including the need to apply an SRHR perspective and incorporate biomedical and structural interventions to address the interacting causes of migrants' vulnerability to HIV/STIs.

Identifiants

pubmed: 34404337
doi: 10.1080/16549716.2021.1962039
pmc: PMC8381899
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1962039

Références

Eval Rev. 2002 Aug;26(4):382-94
pubmed: 12174537
Lancet. 2018 Jun 30;391(10140):2642-2692
pubmed: 29753597
Public Health. 2016 Jul;136:109-16
pubmed: 27184821
Health Educ Res. 2011 Jun;26(3):407-18
pubmed: 21059799
Can J Public Health. 2009 Nov-Dec;100(6):463-6
pubmed: 20209742
Patient Educ Couns. 2009 Apr;75(1):77-83
pubmed: 18950977
Int J Environ Res Public Health. 2019 Apr 10;16(7):
pubmed: 30974851
AIDS Behav. 2015 Mar;19(3):523-35
pubmed: 25179540
Health Place. 2011 Mar;17(2):658-70
pubmed: 21334247
Bull World Health Organ. 2009 Nov;87(11):858-65
pubmed: 20072772
Nurs Res. 2005 Mar-Apr;54(2):108-18
pubmed: 15778652
BMC Public Health. 2015 Dec 10;15:1228
pubmed: 26654427
Eur J Public Health. 2001 Jun;11(2):153-9
pubmed: 11420801
BMC Public Health. 2015 Feb 05;15:82
pubmed: 25652662
Am J Public Health. 2010 Dec;100(12):2532-40
pubmed: 21068423
Eur J Public Health. 2013 Dec;23(6):1039-45
pubmed: 23002238
Patient Educ Couns. 2004 May;53(2):157-65
pubmed: 15140455
Isr J Med Sci. 1993 Oct;29(10 Suppl):48-54
pubmed: 8244681
BMC Med Res Methodol. 2013 Mar 23;13:48
pubmed: 23522333
Am J Public Health. 2004 Mar;94(3):361-6
pubmed: 14998794
Eur J Public Health. 2014 Feb;24(1):139-44
pubmed: 23921295
Prev Med. 2013 Jan;56(1):53-8
pubmed: 23159302
Prev Chronic Dis. 2014 Feb 06;11:130258
pubmed: 24503341
Public Health Rep. 2015 Sep-Oct;130(5):458-67
pubmed: 26327724
Public Health Rep. 2001 Nov-Dec;116(6):599-607
pubmed: 12196620
Emerg Health Threats J. 2009;2:e10
pubmed: 22460280
AIDS Behav. 2011 Nov;15(8):1764-75
pubmed: 21301948
AIDS Behav. 2017 Oct;21(10):2844-2859
pubmed: 28710710
J Hepatol. 2012 Dec;57(6):1171-6
pubmed: 22885717
J Immigr Minor Health. 2012 Feb;14(1):65-81
pubmed: 21773882
J Community Health. 2009 Jun;34(3):165-72
pubmed: 19127416
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Syst Rev. 2012 Nov 20;1:56
pubmed: 23168134
Pediatrics. 2003 Jun;111(6 Pt 1):1278-88
pubmed: 12777542
PLoS One. 2016 Sep 12;11(9):e0162683
pubmed: 27617742
Health Promot J Austr. 2017 Mar;28(1):30-36
pubmed: 27346537
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
AIDS Behav. 2012 Jul;16(5):1316-26
pubmed: 21969175
Curr Opin Infect Dis. 2018 Feb;31(1):25-32
pubmed: 29095720
Am J Public Health. 2011 Dec;101(12):2245-52
pubmed: 22021297
AIDS. 2017 Sep 10;31(14):1979-1988
pubmed: 28857779
AIDS Educ Prev. 2013 Dec;25(6):508-18
pubmed: 24245597
Annu Rev Clin Psychol. 2009;5:143-67
pubmed: 19327028
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1341-9
pubmed: 26104909
AIDS Care. 2004 May;16(4):507-18
pubmed: 15203418
Health Care Women Int. 2011 Mar;32(3):190-205
pubmed: 21337242
Cult Health Sex. 2012;14(5):505-20
pubmed: 22468763
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):782-91
pubmed: 23613027
BMC Public Health. 2015 Jun 19;15:561
pubmed: 26085030
Eur J Public Health. 2017 Feb 1;27(suppl_1):40-46
pubmed: 28355637

Auteurs

Faustine Kyungu Nkulu-Kalengayi (FK)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.

Robert Jonzon (R)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
Department of Sexual Health and HIV Prevention, The Public Health Agency of Sweden, Stockholm, Sweden.

Charlotte Deogan (C)

Department of Sexual Health and HIV Prevention, The Public Health Agency of Sweden, Stockholm, Sweden.

Anna-Karin Hurtig (AK)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH